Antimicrobial Nano
Antimicrobial nanoparticles and coatings using silver, copper, etc.
NanoHorizons
Bellefonte, United States
NanoHorizons, Inc., founded in 2002 and based in Bellefonte, Pennsylvania, has specialized in developing antimicrobial silver nanoparticle technology for textiles and surface treatment applications. With over $20 million in funding and 10-50 employees, the company pioneered commercial applications of silver nanoparticles' potent antibacterial properties, particularly in fabrics and consumer products. NanoHorizons emerged during early enthusiasm for nanotechnology's potential to solve practical problems, focusing on the well-known antimicrobial properties of silver but enhancing them through nanoscale engineering. The company's flagship SmartSilver technology consists of precisely engineered silver nanoparticles and silver-containing compounds that provide sustained antimicrobial protection when incorporated into textiles, coatings, and plastics. At the nanoscale, silver exhibits dramatically enhanced antimicrobial efficacy compared to bulk silver, requiring far smaller quantities to achieve bacterial, fungal, and viral inhibition. This efficiency stems from nanoparticles' high surface-area-to-volume ratios and their ability to release silver ions in controlled manner. NanoHorizons developed application technologies allowing silver nanoparticles to be durably attached to textile fibers, maintaining antimicrobial performance through repeated washing cycles—a critical requirement for commercial textile applications. The company's antimicrobial additives have been incorporated into athletic wear, medical textiles, military uniforms, footwear, and home textiles, providing odor control and hygiene benefits. In healthcare settings, silver nanoparticle-treated fabrics reduce bacterial colonization on hospital linens and scrubs, potentially mitigating infection transmission. NanoHorizons worked with major textile manufacturers and consumer brands to integrate SmartSilver into products, providing technical support for application processes and efficacy testing. The company developed various product forms including aqueous dispersions, powder additives, and master batches compatible with different textile treatment and polymer compounding processes. Beyond textiles, NanoHorizons applied its technology to antimicrobial coatings for surfaces, plastics, and other materials requiring bacterial resistance. The company navigated evolving regulatory landscapes for nanomaterial applications, particularly EPA regulations governing antimicrobial products and consumer safety considerations. As public awareness of nanomaterial safety grew, NanoHorizons invested in toxicology studies and environmental fate research, addressing questions about silver nanoparticle release and ecological impacts. The company's experience illustrates both opportunities and challenges in commercializing consumer-facing nanotechnology applications—while silver nanoparticles deliver clear antimicrobial benefits, regulatory complexity, environmental concerns, and public perception issues complicate market development. NanoHorizons has adapted its strategy over time, emphasizing safe, responsible nanomaterial applications with clear performance benefits. The company represents the cohort of early nanotechnology firms that helped establish commercial nano-enabled consumer products, contributing to understanding how nanomaterials can be responsibly incorporated into everyday products while addressing legitimate safety and environmental concerns.
NanoViricides
Shelton, United States
Developer of nanoviricide drugs designed to attack and destroy viruses
Nanosonics
Sydney, Australia
Global leader in infection prevention with proprietary nanotechnology-based disinfection systems for medical devices
Starpharma Holdings
Melbourne, Australia
World leader in dendrimer nanotechnology for drug delivery and pharmaceutical applications
Nanox Brazil
São Carlos, Brazil
Antimicrobial nanoparticle coatings and additives
HeiQ Materials
Bad Zurzach, Switzerland
Textile innovation using nanotechnology
Starpharma
Melbourne, Australia
Dendrimer nanotechnology for antiviral and oncology therapeutics
Bio-Gate
Nuremberg, Germany
Silver nanotechnology for antimicrobial medical products and consumer goods
Natural Immunogenics
Sarasota, United States
Colloidal silver nanoparticle products for antimicrobial applications
Silversol
Salt Lake City, United States
Silver nanoparticle technology for wound care and antimicrobial applications
Nanordica Medical
Tartu, Estonia
Silver and copper nanoparticle wound care products